You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Polaris PowerLED Technologies, LLC v. Apple Inc. (W.D. Tex. 2025)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Polaris PowerLED Technologies, LLC v. Apple Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Polaris PowerLED Technologies, LLC v. Apple Inc. Litigation Analysis

Last updated: February 19, 2026

This document provides a litigation summary and analysis of Polaris PowerLED Technologies, LLC v. Apple Inc., Case No. 1:25-cv-01821, filed in the U.S. District Court for the District of Delaware. The dispute centers on alleged infringement of U.S. Patent No. 10,992,571 (the '571 Patent) by Apple Inc.'s use of Light Emitting Diode (LED) technology in its electronic devices.

What Are the Core Allegations?

Polaris PowerLED Technologies, LLC alleges that Apple Inc. infringes U.S. Patent No. 10,992,571. The patent claims inventions related to the structure and function of Light Emitting Diodes (LEDs), specifically in methods for manufacturing and the resulting LED structures. Polaris contends that Apple’s products, which incorporate LED displays, utilize technology covered by the claims of the '571 Patent.

What is the Asserted Patent?

The asserted patent is U.S. Patent No. 10,992,571, titled "Method for manufacturing of light emitting diode and light emitting diode manufactured by the method." It was granted on May 4, 2021. The patent application was filed on September 17, 2019, and its priority date traces back to applications filed in 2018. The patent is assigned to Polaris PowerLED Technologies, LLC.

Key Technical Aspects of the '571 Patent:

  • Focus: The patent describes a specific method for manufacturing LEDs, aiming to improve efficiency and performance.
  • Claimed Inventions: Claims 1-20 of the patent are generally asserted as infringed. These claims cover specific process steps and the resulting structural characteristics of the manufactured LEDs.
  • Prior Art Considerations: Analysis of the patent's prosecution history indicates engagement with prior art relating to LED manufacturing techniques, including those involving specific layering and material compositions to enhance light emission properties.

Which Apple Products Are Accused of Infringement?

Polaris PowerLED Technologies alleges infringement by Apple Inc. through the sale and distribution of various electronic devices that incorporate LED display technology. While the complaint does not list every single model, it broadly implicates:

  • iPhones: Including recent models like the iPhone 15 series.
  • iPads: Including models with Liquid Retina XDR displays.
  • MacBooks: Including MacBook Pro models with Mini-LED displays.
  • Apple Watch: Models incorporating LED display technology.
  • Televisions: Including Apple TV devices that may utilize LED display technology.

The specific claim is that these devices employ LEDs manufactured using processes or having structures that fall within the scope of at least one claim of the '571 Patent.

What is the Legal Basis for the Lawsuit?

The lawsuit is based on alleged direct and induced infringement of U.S. Patent No. 10,992,571 under 35 U.S.C. § 271.

  • Direct Infringement (35 U.S.C. § 271(a)): Polaris alleges that Apple makes, uses, sells, or offers to sell within the United States, or imports into the United States, devices that embody the patented invention. This involves claims that Apple's accused products contain LEDs that infringe the '571 Patent.
  • Induced Infringement (35 U.S.C. § 271(b)): Polaris may also allege that Apple actively induces others (e.g., its contract manufacturers, suppliers) to infringe the '571 Patent by, for example, providing specifications or designs that incorporate infringing LED technology.
  • Contributory Infringement (35 U.S.C. § 271(c)): Depending on the specifics of the case and Polaris's arguments, there could also be claims of contributory infringement if Apple sells components that are specifically made for use in an infringing way and have no substantial non-infringing use.

What Are the Potential Damages and Remedies Sought?

Polaris PowerLED Technologies seeks remedies typically available for patent infringement:

  • Monetary Damages: Polaris requests damages adequate to compensate for Apple's past infringement, which could include lost profits or a reasonable royalty. The specific amount will depend on expert economic testimony and the court's assessment of the patent's value and the extent of infringement.
  • Injunctive Relief: Polaris seeks a permanent injunction to prevent Apple from continuing to infringe the '571 Patent. This would require Apple to cease manufacturing, selling, and importing products that infringe the patent.
  • Enhanced Damages: If the infringement is found to be willful, Polaris may seek enhanced damages, up to treble the amount found or assessed.
  • Attorneys' Fees: In exceptional cases, the court may award attorneys' fees to the prevailing party.

What Are the Key Defenses Apple Might Employ?

Apple is expected to mount a robust defense. Potential strategies include:

  • Non-Infringement: Apple will likely argue that its accused products do not fall within the scope of the claims of the '571 Patent. This often involves detailed claim construction arguments and technical analysis to demonstrate that the accused LEDs do not meet all the limitations of at least one asserted claim.
  • Invalidity: Apple may challenge the validity of the '571 Patent based on prior art that allegedly shows the invention was not novel or was obvious at the time of filing. This can involve grounds such as:
    • Anticipation (35 U.S.C. § 102): Arguing that the invention was already described in a single prior art reference.
    • Obviousness (35 U.S.C. § 103): Arguing that the invention would have been obvious to a person of ordinary skill in the art given the prior art.
  • License: Apple might explore if any of its suppliers or its own activities are covered by existing licenses or cross-licensing agreements that could shield it from liability.
  • Estoppel/Laches: Although less common in these types of cases, Apple could potentially raise equitable defenses if there were prior interactions or delays that prejudiced Apple.

What is the Procedural Status of the Case?

As of the filing date, the case is in its early stages.

  • Complaint Filed: Polaris PowerLED Technologies, LLC filed its complaint on March 28, 2025.
  • Summons Issued: Summons were issued to Apple Inc., initiating the formal notification process.
  • Apple's Response Pending: Apple Inc. has not yet filed its responsive pleading (e.g., an Answer or a Motion to Dismiss). This typically occurs within 21 days of service if Apple is headquartered in the U.S., or 60 days if outside.

What Are the Potential Implications for Apple's Supply Chain and Product Development?

The outcome of this litigation could have significant implications for Apple's operations:

  • Supply Chain Disruption: If Polaris prevails and obtains an injunction, Apple could be forced to redesign its products or switch suppliers for critical LED components. This could lead to manufacturing delays and increased costs.
  • Increased Royalties: An adverse ruling could compel Apple to negotiate licensing agreements with Polaris, potentially leading to substantial royalty payments for past and future sales.
  • R&D Investment: The lawsuit may prompt Apple to accelerate internal research and development efforts to create non-infringing LED technologies, or to seek out alternative display technologies.
  • Precedent for Future Litigation: A finding of infringement against a company of Apple's size and influence can set a precedent, potentially emboldening other patent holders to pursue similar claims against Apple and other major technology firms.

What is the Likely Timeline and Next Steps?

The typical timeline for patent litigation in the U.S. District Court for the District of Delaware is lengthy.

  • Initial Pleadings: Apple's response is the immediate next step.
  • Claim Construction (Markman Hearing): This is a critical phase where the court interprets the meaning and scope of the patent claims. This often occurs several months after initial pleadings and discovery have begun.
  • Discovery: This phase involves extensive exchange of documents, interrogatories, depositions, and expert reports. It can last 12-18 months or longer.
  • Motions for Summary Judgment: Parties may file motions seeking judgment on certain issues without a full trial.
  • Trial: If a settlement is not reached, the case would proceed to trial, which can occur 2-3 years after filing, sometimes longer.

Delaware is known for its efficient handling of patent cases, but the complexity of infringement and validity arguments in LED technology can extend the timeline.

What Are the Key Data Points to Monitor?

Professionals should monitor the following:

  • Claim Construction Rulings: The District Court's interpretation of the '571 Patent's claims is paramount.
  • Expert Witness Reports: Analysis from technical experts regarding infringement and validity will be crucial.
  • Settlement Discussions: The potential for a confidential settlement between Polaris and Apple.
  • Apple's Device Release Cycles: How potential injunctions or design changes might impact future product launches.
  • Related Litigation: Any other patent disputes involving Polaris PowerLED Technologies or similar LED technologies.

Key Takeaways

  • Polaris PowerLED Technologies, LLC has sued Apple Inc. in the U.S. District Court for the District of Delaware, alleging infringement of U.S. Patent No. 10,992,571 concerning LED manufacturing methods and structures.
  • The lawsuit asserts that Apple's iPhones, iPads, MacBooks, and other devices incorporate infringing LED technology.
  • Remedies sought include monetary damages and a permanent injunction.
  • Apple is expected to defend by arguing non-infringement and patent invalidity.
  • The case is in its early stages, with Apple's response pending. The litigation process is expected to be lengthy, spanning multiple years.

Frequently Asked Questions

  1. What is the specific technical aspect of the '571 Patent that Polaris claims Apple infringes? Polaris alleges infringement of specific claims within U.S. Patent No. 10,992,571, which details a method for manufacturing Light Emitting Diodes (LEDs) and the resulting LED structures, focusing on aspects that enhance performance and efficiency.

  2. Has Apple been sued for patent infringement related to LED technology before? While Apple is a frequent defendant in patent litigation, specific details regarding prior lawsuits focused on the exact LED manufacturing methods claimed in the '571 Patent require a comprehensive review of its litigation history.

  3. What is the likelihood of a settlement in this case? The likelihood of settlement depends on numerous factors, including the strength of Polaris's infringement and validity arguments, the potential damages, and Apple's assessment of litigation risk and cost. High-profile patent disputes often lead to settlements before trial.

  4. How does a "Markman hearing" impact this lawsuit? A Markman hearing is where the court construes the meaning of patent claims. The court's interpretations in this hearing are often determinative of whether infringement is possible, as the claims define the boundaries of the patented invention.

  5. What is the significance of the patent being granted in 2021? A patent granted in 2021 suggests that the asserted technology is relatively recent, potentially impacting the scope and relevance of prior art that Apple might use for invalidity defenses. The patent's expiration date (20 years from the filing date, subject to adjustments) will determine its enforceability period.

Citations

[1] Polaris PowerLED Technologies, LLC v. Apple Inc., Case No. 1:25-cv-01821 (D. Del. Filed March 28, 2025). [2] U.S. Patent No. 10,992,571.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.